Global In Vitro fertilization Market Size, Growth, Opportunity and Forecast 2022-2030

  • Product Code:
    RP-ID-10008244
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Pages:
    144
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-12

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

" The Global In Vitrofertilization (IVF) market is estimated to be valued at ~USD 16 billion by end of 2021 and is projected to expand at a CAGR of ~7% from 2022 to 2030. One of the most important and market drivers of growth is: Born tourism. Incidence of infertility in men and women.Childbirth is one of the biggest health problems for people around the world. According to the American Pregnancy Association, male infertility cases account for 30.0% of infertility cases and about one fifth of infertility cases. Also, literate women prefer to plan family plans later for career guidance. This makes women more dependent on infertility treatment as fertility decreases with age. 

 

In vitro fertilization (IVF) method. In December 2016, the Ontario government announced a $50 million birth program that would cover $50 million in IVF treatment. Additionally, the Singapore government has provided approximately 75% of total funding for various ART procedures such as in vitro fertilization, playful fallopian tube transplantation (GIFT) and intracytoplasmic sperm injection (ICSI). In January 2015, the US Centers for Disease Control and Prevention (CDC) reported that the use of ICSI for new product development increased from 36.4% in 1996 to approximately 76.2% (and TESE) in 2012. 

 

In June 2018, Australian scientists used an artificial intelligence tool called Ivy to determine which fetus is most likely to conceive. These technologies have helped increase IVF pregnancy success rates as the COVID-19 pandemic hampers infertility treatment and women give up mental illness. 

 

A study published by the American Society for Reproductive Medicine found that restrictions on COVID-19 were relaxed, with about 62% of participants wanting to start treatment by October 2020. Medical centers can begin effective treatment immediately if certain guidelines are followed. The Human Reproductive and Embryology Organization has issued a permit to resume treatment in June 2020.

 

INSTRUMENT INFORMATION: 


 The cultural media sector dominates the IVF market and will account for the largest revenue share in 2020, exceeding 38%, due to the availability of funds and increased research activities to strengthen cultural media. However, as industry players introduce disposable devices such as needles, slides, and chambers to meet sterility and regulatory requirements, the disposable device segment is expected to grow at the fastest rate in the next few years.

 

PROCEDURAL INFORMATION:


The fresh non-donor segment dominates the IVF market and will account for the highest revenue share of 40% in 2020. This increase is due to the high first attempt success rate of the program. Since this procedure can be performed even in complex situations, this segment of the market may achieve the fastest growth in the next few years. For example, patients with ovarian hyperstimulation syndrome (OHSS) may choose this type of IVF surgery.

 

 END USE INSIGHT: 


The fertility clinic sector dominates the IVF market and will account for approximately 77% of the largest revenue share in 2020, and may dominate the entire forecast period. As the demand for ART treatment increases, the number of fertility clinics and ART centers has also increased significantly. Factors such as cost-effectiveness, availability of specialists, and little or no possibility of hospital-acquired infections are some of the key factors attributable to the growth of fertility clinics.

 

REGIONAL INFORMATION: 


 Due to factors such as medical tourism and legal reviews related to IVF technology, Europe dominates the IVF market and will account for the largest revenue share in 2020 at 37.0%. More and more Americans are heading to the Czech Republic to enjoy low-cost IVF treatment.

 

  KEY COMPANIES AND MARKET SHARE PROSPECTS: 


Geographic expansion, mergers, and product innovation and commercialization are key strategies for market participants to operate in the market. In July 2019, Vitrolife and Prime Tech signed a cooperation agreement to design and commercialize piezoelectric technology to improve intracytoplasmic sperm for human IVF on a global scale (except Thailand, Japan, and Malaysia) Injection (ICSI) procedure. Some of the major players in the IVF market include: OvaScienceEMD Serono Inc. Vitrolife ABIrvine ScientificCook Medical Inc Cooper Surgical Inc. Genea Biomedx Thermo Fisher Scientific Inc. Progyny, Inc. Boston IVF

 

 MARKET SEGMENTS  COVERED BY THE REPORT : 


The report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research will report on the global IVF market based on instrument, procedure type, end use, and region: Instrument Outlook (Revenue, USD Million, 2022-2030) Medium-sized Disposable Equipment Cultivation Equipment Capital Equipment Procedure Type Outlook (income, USD million, 2022-2030) Fresh donors, frozen donors, non-fresh donors, non-frozen donors, end-use outlook (income, USD million, 2022-2030) Fertility clinics, hospitals and other environments. "
 


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

1. Coopersurgical Inc. (A Subsidiary of the Cooper Companies, Inc.)
2. Vitrolife AB
3. Cook Medical Inc.
4. Irvine Scientific
5. Thermo Fisher Scientific Inc.
6. EMD Sereno Inc. (Merck KGaA)
7. Genea Limited
8. Esco Micro Pte. Ltd.
9. IVFtech APS
10. The Baker Company, Inc.
11. Kitazato Corporation
12. Rocket Medical PLC.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->